The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …

Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active
against resistant Gram-negative bacterial infections. Over the past decade, their use in …

Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Background Carbapenem-resistant Enterobacteriaceae (CRE) is a major concern leading to
morbidity and mortality in the world. CRE often is becoming a cause of therapeutic failure in …

Objective Carbapenem-resistant Enterobacteriaceae (CRE) has become a significant public
health problem in the last decade. We aimed to explore the risk factors of mortality in …

Infections by carbapenem-resistant Klebsiella pneumoniae (CR Kp) are an increasing
global threat with limited therapeutic options. Our objective was to evaluate clinical and …

Background Kidney transplant recipients are a risk group for carbapenem-resistant
Enterobacteriaceae infection. Objectives This study aimed to identify risk factors for CRE …

We aimed to describe the effect of aminoglycosides and tigecycline to reduce the mortality in
colistin-and carbapenem-resistant Klebsiella pneumoniae (ColR-CR-Kp) infections. We …

Abstract Background For resistant Gram-positive bacteria, evidence suggests that
combination therapy is more effective. However, for resistant Gram-negative bacteria, no …

Objective: The antimicrobial activities of the synergistic combination of carvacrol and
polymyxin B against polymyxin-resistant Klebsiella pneumoniae were evaluated. Methods …